European Commission seeks feedback on Sanofi anti-competition commitments
The European Commission is inviting public comments on proposed commitments from Sanofi regarding concerns over the company's marketing practices for its influenza vaccine.
AI disclosure: Summarised from a single named source by an AI model with editorial rules; links to the original report.
The European Commission has invited stakeholders to provide feedback on commitments offered by Sanofi to resolve concerns regarding potentially anti-competitive behaviour. According to the European Commission, the issue relates to a promotional campaign that may have disparaged a rival influenza vaccine. The competitor product is reportedly the only other flu vaccine recommended for patients considered vulnerable due to specific risk factors.
The Commission is now seeking input on these proposed measures to determine if they effectively address the identified competition concerns. These commitments follow an investigation into whether the communication campaign hindered fair competition within the vaccine market. Stakeholders have been invited to submit their views on the adequacy of the steps offered by the pharmaceutical company.
Source: European Commission. Read the original report ↗
Source ledger
-
This brief is based on reporting by European Commission.supports: European Commission